0

Xstrahl is going to the 5th annual Preclinical Imaging Consortium

Xstrahl is attending the 5th annual Preclinical Imaging Consortium taking place on 28 – 30 April 2019 at Northwestern University, Evanston, IL. The event’s agenda this year features presentations [...]

0

Xstrahl attended Nevskiy Radiology Forum in St.-Petersburg

Xstrahl has just returned from the Nevskiy Radiology Forum which took place in St.-Petersburg, Russia on the 12th – 13th of April. The Nevskiy Forum is an established platform gathering together [...]

0

International Symposium on Standards, Applications and Quality Assurance in Medical Radiation Dosimetry (IDOS 2019)

18 – 21 June 2019 (Vienna, Austria)

0

World Preclinical Congress

17 – 21 June 2019 (Boston, US)

0

Xstrahl In Action: Low dose treatment counteracts and enhances the anti-tumor effect

The extent of tumor oxygenation is an important factor contributing to the efficacy of radiation therapy. Several preclinical studies have shown benefit of combining radiation therapy with drugs [...]

0

DEGRO 2019

13 – 16 June 2019 (Münster, Germany)

0

Xstrahl In Action: Identification of protein targets for AVM molecular therapies

Current treatment methods for arteriovenous malformation (AVM) are surgery and radiosurgery. However, complete occlusion post radiosurgery is achieved within 3 years, while patient remain at risk [...]

0

Xstrahl is targeting optimal care at ESTRO 38

Xstrahl would like to invite you to join them in targeting optimal care at ESTRO 38, 26th-30th April 2019 in Milan, Italy. Xstrahl is launching the new Xstrahl 150 at the event, its fully [...]

0

Xstrahl In Action: Evaluation of in vitro PARP-1 inhibitors for use in neuroblastoma treatment

The radiopharmaceutical (131)I-meta-iodobenzylguanidine ((131)I-MIBG) is an effective treatment for neuroblastoma. However, maximal therapeutic benefit from (131)I-MIBG is likely to be obtained [...]